Healthmap Solutions, a national population health management company focused on kidney disease, announced today that it has raised $100mm to support the ongoing expansion of its business. Healthmap has grown rapidly with its health plan customers and is currently contracted to serve over 160,000 individuals living with kidney disease.

Funds managed by Healthmap's largest investor, WindRose Health Investors, led the financing along with participation from existing investors.

Healthmap Solutions is an NCQA-accredited kidney population health management company serving health plans, health systems, accountable care organizations, and provider groups seeking a value-based solution to improve the lives of Americans living with chronic kidney disease. Using its advanced predictive analytics technology and clinical expertise, Healthmap provides early kidney disease identification and recommends clinically proven interventions to delay or slow disease progression. Healthmap Care Navigation teams work with patients and the full spectrum of a health plan's providers to maintain access, minimize disruption and deliver personalized whole-person care from trusted providers. Healthmap's approach is to proactively plan care transitions and optimize renal replacement therapy, with a focus on in-home dialysis treatment and transplant. This approach improves care, outcomes, and patient experience while lowering total medical costs for health plans and provider groups.